Financials

News Ideas Discussions Technicals Seasonals

4016 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to MIDDLE EAST PHARMACEUTICAL INDUSTRIES CO. operating, investing, and financing activities

4016 free cash flow for Q4 24 is 19.2 M SAR. For 2024, 4016 free cash flow was 20.45 M SAR and operating cash flow was 31.62 M SAR.

Q2 '22

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SAR

Q2 '22

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—